FindTrial
Sign In

Changes in follicular T helper cells in patients with lupus nephritis after Belimumab treatment: an observational study

Changes in follicular T helper cells in patients with lupus nephritis after Belimumab treatment: an observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400082978
Enrollment
Unknown
Registered
2024-04-12
Start date
2024-04-15
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lupus nephritis

Interventions

Belimumab exposed group:None
Belimumab unexposed group:None

Sponsors

The Fifth Affiliated Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients who have been diagnosed with lupus nephritis according to the 2019ACR/EULAR SLE classification standard and the 2012 ACR definition of LN 2. Patients aged 18-70 years old.

Exclusion criteria

Exclusion criteria: 1. Patients with co-infection with bacteria/viruses (hepatitis B, hepatitis C and tuberculosis) 2. Patients with tumor 3. Combined with other autoimmune diseases, such as rheumatoid arthritis, systemic vasculitis, scleroderma and dermatomyositis. 4. Kidney dialysis patients.

Design outcomes

Primary

MeasureTime frame
Follicular T helper cells;—

Countries

China

Contacts

Public ContactZhong Shuping

The Fifth Affiliated Hospital, Sun Yat-sen University

zhshup@mail.sysu.edu.cn+86 139 2692 7926

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026